IRadimed Corp (IRMD) stock
IRMDNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 30, 2026Score 19/3060% above fair value
$85.35+0.12 (+0.14%)
Close on Nov 13, 2026Market cap $1.09BP/E 45.6Yield –
IRadimed r&d expenses
Research and development expenses are spending on new products and technology.
IRadimed's R&D Expenses for the twelve months ending Sep 30, 2026 was $3.29M, up 19.7% year over year. For fiscal 2025 it was $2.98M, up 5.0% from the year before. Over ten years it grew 5.4% a year on average. The highest annual figure on record is $2.98M in fiscal 2025.
Annual r&d expenses
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.98M | +5.0% |
| FY2024 | Dec 31, 2024 | $2.83M | -0.9% |
| FY2023 | Dec 31, 2023 | $2.86M | +25.5% |
| FY2022 | Dec 31, 2022 | $2.28M | +19.6% |
| FY2021 | Dec 31, 2021 | $1.91M | +0.1% |
| FY2020 | Dec 31, 2020 | $1.90M | +32.8% |
| FY2019 | Dec 31, 2019 | $1.43M | -5.6% |
| FY2018 | Dec 31, 2018 | $1.52M | -11.9% |
| FY2017 | Dec 31, 2017 | $1.72M | +27.8% |
| FY2016 | Dec 31, 2016 | $1.35M | -23.6% |
| FY2015 | Dec 31, 2015 | $1.76M | +65.1% |
| FY2014 | Dec 31, 2014 | $1.07M | +5.8% |
| FY2013 | Dec 31, 2013 | $1.01M | – |
Quarterly r&d expenses
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $875.00K | +29.8% |
| Q2 FY2026 | Jun 30, 2026 | $657.00K | -25.1% |
| Q1 FY2026 | Mar 31, 2026 | $956.00K | +53.2% |
| Q4 FY2025 | Dec 31, 2025 | $799.00K | +40.1% |
| Q3 FY2025 | Sep 30, 2025 | $674.00K | +5.4% |
| Q2 FY2025 | Jun 30, 2025 | $877.00K | +9.5% |
| Q1 FY2025 | Mar 31, 2025 | $624.00K | -24.0% |
| Q4 FY2024 | Dec 31, 2024 | $570.40K | -12.3% |
| Q3 FY2024 | Sep 30, 2024 | $639.47K | +41.3% |
| Q2 FY2024 | Jun 30, 2024 | $801.13K | -16.7% |
| Q1 FY2024 | Mar 31, 2024 | $821.00K | -72.6% |
| Q4 FY2023 | Dec 31, 2023 | $650.44K | +7.6% |
| Q3 FY2023 | Sep 30, 2023 | $452.56K | -8.0% |
| Q2 FY2023 | Jun 30, 2023 | $961.95K | +45.2% |
| Q1 FY2023 | Mar 31, 2023 | $3.00M | +477.9% |
| Q4 FY2022 | Dec 31, 2022 | $604.74K | +22.2% |
| Q3 FY2022 | Sep 30, 2022 | $491.64K | +2.3% |
| Q2 FY2022 | Jun 30, 2022 | $662.60K | +46.1% |
| Q1 FY2022 | Mar 31, 2022 | $519.10K | +9.1% |
| Q4 FY2021 | Dec 31, 2021 | $494.85K | -3.5% |
| Q3 FY2021 | Sep 30, 2021 | $480.70K | +0.8% |
| Q2 FY2021 | Jun 30, 2021 | $453.68K | -6.0% |
| Q1 FY2021 | Mar 31, 2021 | $475.82K | +10.6% |
| Q4 FY2020 | Dec 31, 2020 | $512.72K | +35.2% |
| Q3 FY2020 | Sep 30, 2020 | $476.88K | +29.1% |
| Q2 FY2020 | Jun 30, 2020 | $482.65K | +45.7% |
| Q1 FY2020 | Mar 31, 2020 | $430.28K | +22.0% |
| Q4 FY2019 | Dec 31, 2019 | $379.31K | +3.2% |
| Q3 FY2019 | Sep 30, 2019 | $369.53K | -1.1% |
| Q2 FY2019 | Jun 30, 2019 | $331.31K | -16.3% |
| Q1 FY2019 | Mar 31, 2019 | $352.57K | -7.2% |
| Q4 FY2018 | Dec 31, 2018 | $367.72K | +5.2% |
| Q3 FY2018 | Sep 30, 2018 | $373.58K | -2.4% |
| Q2 FY2018 | Jun 30, 2018 | $395.99K | -11.8% |
| Q1 FY2018 | Mar 31, 2018 | $379.83K | -29.8% |
| Q4 FY2017 | Dec 31, 2017 | $349.56K | -4.0% |
| Q3 FY2017 | Sep 30, 2017 | $382.70K | – |
| Q2 FY2017 | Jun 30, 2017 | $449.01K | – |
| Q1 FY2017 | Mar 31, 2017 | $541.29K | – |
| Q4 FY2016 | Dec 31, 2016 | $364.22K | – |
See a number that looks wrong?